Product Recalls in 2019
4,851 recalls issued this year
241
CPSC
1,807
FDA Food
1,788
FDA Drug
1,015
NHTSA
FDA Drug
Class II
Terminated
LEUCOVORIN 560 MG / 250 ML NS IVPB; LEUCOVORIN 830 MG / 250 ml NS IVPB; LEUCOVORIN 300 MG / 50 ml D5W IVPB; LEUCOVORIN 840 MG / 250 ml NS IVPB; LEUCOVORIN 750 MG / 250 ml NS IVPB; LEUCOVORIN 690 MG /
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
NIVOLUMAB 480 MG / 100 ML NS IVPB; NIVOLUMAB 200 mg / 100 ML NS IVPB; NIVOLUMAB 165 mg / 100 ML NS IVPB; NIVOLUMAB 240 mg / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
RITUXAN 728 MG QS 728 mL 0.9% NACL IVPB; RITUXAN 560 MG / 306 ml 0.9% NACL; RITUXAN 562 MG IN 562 ml 0.9% NACL; RITUXAN 700 MG QS 700 mL 0.9% NACL IVPB; RITUXAN 1000 MG / 350 mL 0.9% NACL IVPB RI
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
PACLITAXEL 258 MG / 500 ML NS IVPB; PACLITAXEL 318 MG / 500 ML NS IVPB; PACLITAXEL 385 MG / 500 ML NS IVPB; PACLITAXEL 340 MG / 500 ML NS IVPB; PACLITAXEL 332 MG / 500 ML NS IVPB; PACLITAXEL 250 MG /
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
CARFILZOMIB 65 MG IN 50 ML D5W IVPB; CARFILZOMIB 75 MG IN 50 ML D5W IVPB; CARFILZOMIB 50 MG IN 50 ML D5W IVPB; CARFILZOMIB 45 MG IN 50 ML D5W IVPB; CARFILZOMIB 46.2 MG IN 50 ML D5W IVPB, Rx Only, Infu
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
Cisplatin 40 MG / 500 ml NS IVPB WITH Mannitol 40 G; Cisplatin 80 MG / 250 ml 0.9% NACL; Cisplatin 44 MG QS 500 ml NS IVPB; Cisplatin 40 MG / 500 ml 0.9% NACL; Cisplatin 36 MG / 500 ML NS IVPB; Cispla
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
RAMUCIRUMAB 457 MG QS 250 ML NS IVPB; AMUCIRUMAB 1182 MG QS 250 ML NS IVPB; Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
Adcetris 96 MG/100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
FOSAPREPITANT 150 mg/150 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
NHTSA
Ongoing
Driveshaft Bolts May Loosen
June 12, 2019
PORSCHE CARS NORTH AMERICA, INC.
3 units
FDA Drug
Class II
Terminated
DIPHENHYDRAMINE 25 MG/50 ML NS, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
Gemcitabine 1910 MG / 250 ML NS IVPB; Gemcitabine 1140 MG / 250 ML NS 0.9% IVPB; Gemcitabine 1290 MG /250 ML NS IVPB; Gemcitabine 460 MG / 250 ML NS IVPB; Gemcitabine 880 MG / 250 ML NS IVPB; Gemcitab
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
CALCIUM GLUCONATE 1 GM /100 ML NACL 0.9% IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
INJECTAFER 720 MG in 100 ml NS IVPB; INJECTAFER 210 MG in 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
ATEZOLIZUMAB 1200 MG / 250 ML 0.9% NACL, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
DOCETAXEL 60 MG / 250 ml D5W IVPB; DOCETAXEL 71 MG/ 250 ML NS IVPB; DOCETAXEL 155 MG/ 250 ml NS IVPB; DOCETAXEL 110 mg / 250 ml NS IVPB; DOCETAXEL 150 MG / 250 ml NS IVPB; DOCETAXEL 137 mg / 250 ml 0.
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
FERRIC CARBOXYMALTOSE 750mg/50ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
MITOMYCIN 10 MG /20 ML IVP SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
Cytarabine 128 MG/250 ML D5W IVPB; Cytarabine 20 MG / 1 ML SQ SYRINGE Cytarabine 70 MG QS 6 ML PF NS SYRINGE; Cytarabine 100 MG QS 3 ML PF NS SYRINGE, Rx Only, Infusion Options, Inc. 5924 13the Ave,
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
GRANISETRON 1000 MCG / 50 ML NS, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
NHTSA
Ongoing
Brake Light may Randomly Illuminate
June 12, 2019
Godwin Manufacturing Company, Inc.
10 units
NHTSA
Ongoing
Front Axles may be Insufficiently Lubricated
June 12, 2019
Daimler Trucks North America LLC
809 units
FDA Drug
Class II
Terminated
PACLITAXEL PROTEIN 175 MG/100 ML NS IVPB; PACLITAXEL PROTEIN 190 MG/100 ML NS IVPB; PACLITAXEL PROTEIN 355 MG/100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 7
June 12, 2019
Infusion Options, Inc.
N/A units
NHTSA
Ongoing
Missing Lamps and Reflective Tape
June 12, 2019
Vac-Tron Equipment, LLC
208 units
FDA Drug
Class II
Terminated
PACLITAXEL ALBUMIN 185 mg /100 ml NS IVPB; PACLITAXEL ALBUMIN 160 MG / 100 ml NS IVPB; PACLITAXEL ALBUMIN 145 MG / 100 ml NS IVPB PACLITAXEL ALBUMIN 165 mg / 100 ml NS IVPB; PACLITAXEL ALBUMIN 150 mg
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
OXALIPLATIN 145 MG /250 ML D5W IVPB; OXALIPLATIN 154 MG / 250 ML D5W IVPB; OXALIPLATIN 130 MG / 250 ML D5W IVPB; OXALIPLATIN 140 MG / 250 ml D5W IVPB; OXALIPLATIN 162 MG / 250 ML D5W IVPB; OXALIPLATIN
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
BLEOMYCIN 18 UNITS / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
InFLIXimab 300 mg / 250 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class III
Terminated
Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total contents: 110 mL to deliver 90 mL, Manufactured by: Cipla Ltd, Verna Goa, India
June 12, 2019
InvaGen Pharmaceuticals, Inc.
1776 bottles units
FDA Food
Class II
Terminated
70% Dark Chocolate Buttons packaged in cellophane bags, zip bags (plastic bag with Ziploc closure), a bulk bin in the factory store. Net wt. 3 oz., 8 oz., 16 oz., 3 lbs (48 oz.) UPC on 3 oz. bag:
June 12, 2019
Euphoria Trading Company, LLC.
301 bags total (3oz. = 84; 8oz = 97; 16oz = 66; 3lbs = 54) units
FDA Drug
Class II
Terminated
PEMETREXED 910 MG QS 100 ML NS IVPB; PEMETREXED 940 mg QS 100 ml NS IVPB; PEMETREXED 1000 mg QS 100 ml 0.9% NACL IVPB; PEMETREXED 490 MG /100 ml NS IVPB; PEMETREXED 800 mg/ 100 ml NS IVPB, Rx Only, I
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
Doxorubicin 110 MG / 55 ML IVP SYRINGE; Doxorubicin 56 MG / 28 ML IVP SYRINGE; Doxorubicin 75 MG / 37.5 ML IVP SYRINGE; Doxorubicin 125 MG / 62.5 ML SYRINGE IVP; Doxorubicin 93 MG / 46.5 ML IV SYRINGE
June 12, 2019
Infusion Options, Inc.
N/A units
NHTSA
Ongoing
Incorrect ORC Calibration
June 12, 2019
Chrysler (FCA US LLC)
869 units
FDA Drug
Class II
Terminated
BEVACIZUMAB 784 MG / 100 ML NS IVPB; BEVACIZUMAB 350 MG/100 ml NS IVPB; BEVACIZUMAB 425 MG/ 100 ml NS IVPB; BEVACIZUMAB 420 MG/100 ml 0.9% NACL IVPB; BEVACIZUMAB 556 mg/100 ml NS IVPB BEVACIZUMAB 330
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
DACARBAZINE 680 MG in 250 ml NS; DACARBAZINE 675 MG in 250 ml NS, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
CPSC
Ongoing
Mares Recalls Buoyancy Compensation Vests Due to Drowning Hazard
June 12, 2019
About 600 units
FDA Drug
Class II
Terminated
ORENCIA 750 mg QS 100 ml 0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
PRESERVATIVE FREE 0.9% NACL 5 ML SYR, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
Abraxane 170 MG / 34 ML IVPB; Abraxane 200 MG / 40 ML IVPB; Abraxane 180 MG / 36 ML IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
NHTSA
Ongoing
Left, Rear Brake Caliper may Drag
June 12, 2019
Daimler Trucks North America LLC
11,546 units
FDA Drug
Class II
Terminated
GAZYVA 100 MG IN 250 ML NS IVPB; GAZYVA 900 MG IN 250 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
IRINOTECAN 250 MG /500 ml D5W IVPB; IRINOTECAN 110 MG /250 ML D5W IVPB; IIRINOTECAN 250 MG/250 ML NS IVPB; IRINOTECAN 315 MG / 250 ML NS IVPB; IRINOTECAN 155 MG / 500 ml D5W IVPB; IRINOTECAN 75 MG / 2
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
METHYLPREDNISOLONE 10 MG / 0.16 ML IVP, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
VINCRISTINE 1 MG /50 ML NS IVPB; VINCRISTINE 1.2 MG /50 ML NACL 0.9% IVPB; VINCRISTINE 1 MG / 1 ML IVP SYRINGE; VINCRISTINE 2 MG /100 ML D5W IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brook
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
PANITUMUMAB 400 MG / 100 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
REMICADE 680 MG QS 250 ML 0.9% NACL IVPB; REMICADE 270 MG QS 250 ML 0.9% NACL IV; REMICADE 730 MG QS 250 ML 0.9% NACL IVPB REMICADE 330 MG QS 250 ML 0.9% NACL IVPB; REMICADE 740 MG IN 250 ML NS IVPB;
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
BORTEZOMIB 2.5 mg / 1 ML SQ SYRINGE; BORTEZOMIB 2.88 MG / 1.15 ML SQ SYRINGE; BORTEZOMIB 2.31 MG / 0.92 ml SQ SYRINGE; BORTEZOMIB 2.7 mg / 1.08 ML SQ SYRINGE; BORTEZOMIB 1.45 mg / 0.58 ml SQ SYRINGE;
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
PERTUZUMAB 840 MG/250 ml0.9% NACL IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
Cyclophosphamide 840 MG / 250 ML NS IVPB; Cyclophosphamide 1112 MG / 250 ML NS IVPB; Cyclophosphamide 1248 MG / 50 ML NS IVPB; Cyclophosphamide 1125 MG / 100 ML NS IVPB; Cyclophosphamide 1000 MG / 500
June 12, 2019
Infusion Options, Inc.
N/A units
FDA Drug
Class II
Terminated
DARZALEX 1008 MG / 500 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233
June 12, 2019
Infusion Options, Inc.
N/A units